Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.22 +0.02 (+0.48%)
At close: Nov 11, 2026 · 4:00 PM EST

Atea Pharmaceuticals (AVIR) Price to Earnings (2021 - 2022)

Updated

Atea Pharmaceuticals' (AVIR) Price to Earnings came in at 13.29 for Q3 2022, down 88.7% from 117.81 a year earlier and down 65.1% from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Price to Earnings (2021 - 2022) Analysis & Trends

For FY2021, Atea Pharmaceuticals' Price to Earnings stood at 6.13.

  • Quarterly Price to Earnings has run from a low of 6.13 in Q4 2021 to a high of 215.08 in Q1 2021 over five years.
  • On a year-over-year basis, Price to Earnings has declined in each of the last three quarters.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 38.07 (Q2 2022), 12.42 (Q1 2022) and 6.13 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Atea Pharmaceuticals 337.28 Mn -631.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 13.29
Jun 30, 2022 38.07
Mar 31, 2022 12.42
Dec 31, 2021 6.13
Sep 30, 2021 117.81
Jun 30, 2021 50.39
Mar 31, 2021 215.08
API Access

Atea Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=AVIR&period=max&api_key=YOUR_API_KEY